Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

President Donald Trump's tariff policies have made Indy small store owners get creative. Some are stocking fewer products or raising prices.

Here are some highlights from the first half of the year: ...

Eli Lilly joins up with Camurus to make long-acting versions of the pharma's obesity and diabetes drugs, joining the industry ...

Although as of this week the stock has declined by more than 4% since the start of the year, there's little reason to believe ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.